New York appears poised to become the latest state to adopt a drug take-back law, a slow-but-steady notion moving across the country as local governments grapple with budget constraints caused by unwanted or unused medicines and the opioid crisis. And the financial burden would, once again, fall on the pharmaceutical industry.
The New York state legislature last week unanimously passed a bill that would require drug makers to underwrite the cost of collecting and disposing of medicines. The measure must now be sent to New York Gov. Andrew Cuomo. We asked his office for comment and will pass along any reply. Last year, Cuomo vetoed a bill that would have required pharmacy chains — not drug makers — to largely pay for a statewide program.